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Abstract
Background: Medically unexplained physical symptoms (MUPS) are highly prevalent and are associated with
frequent health care use (HCU). MUPS frequently co-occur with psychiatric disorders. With this study we examined
the longitudinal association between MUPS and HCU over 2 years and the influence of depressive and anxiety
disorders and personality traits on this association.
Methods: We analysed follow-up data from 2045 to 2981 participants from the Netherlands Study of Depression
and Anxiety (NESDA), a multisite cohort study. The study population included participants with a current depressive
and/or anxiety disorder, participants with a lifetime risk and/or subthreshold symptoms for depressive and/or
anxiety disorders and healthy controls. HCU, measured with the Trimbos and iMTA questionnaire on Costs
associated with Psychiatric illness (TIC-P), was operationalized as the number of used medical services and the
number of associated contacts. MUPS were measured with the Four Dimensional Symptoms Questionnaire,
depressive and anxiety disorders with the Composite International Diagnostic Interview and personality traits with
the NEO Five-Factory Inventory. Measurements were taken at baseline, 1 and 2 years follow-up. We used
generalized estimating equations (GEE), using HCU at all three measurements as (multivariate) outcome. GEE also
takes into account the dependency of observations within participants.
Results: MUPS were positively associated with HCU over 2 years (medical services: RR 1.020, 95 % CI 1.017–1.022;
contacts: RR 1.037, 95 % CI 1.030–1.044). Neuroticism and depression had the strongest influence on the
associations. After adjustment for these factors, the associations between MUPS and HCU weakened, but remained
significant (services: RR 1.011, 95 % CI 1.008–1.014; contacts: RR 1.023, 95 % CI 1.015–1.032).
Conclusions: Our results show that MUPS were positively associated with HCU over 2 years, even after adjusting
for depressive and anxiety disorders and personality traits.
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disorders, Personality traits
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Background
Medically unexplained physical symptoms (MUPS), phys-
ical symptoms that cannot be explained or not sufficiently
explained by an underlying medical condition after ad-
equate examination, are highly prevalent in all health care
settings [1–5]. MUPS represent a broad spectrum of symp-
toms in varying degrees of severity, ranging from acute,
mild MUPS to severe and chronic MUPS [6, 7]. It is known
that patients with MUPS have a high health care use
(HCU) leading to high costs [8–10]. Therefore, MUPS put
a burden not only on patients and physicians, but also on
society in a time when health care costs are steadily rising.
This high HCU is regularly attributed to patients pres-
surizing their general practitioner (GP) for a somatic
treatment for their symptoms. However, several studies
suggest that most patients do not request somatic inter-
ventions but want support and acknowledgement of the
reality of their symptoms, but instead receive interven-
tions initiated by the GP [11, 12].
Several studies showed that patients with MUPS use
disproportionally large amounts of mostly somatic
health care services and not particularly mental health
care services [13, 14]. Barsky et al. for instance found
that primary care patients with MUPS had approxi-
mately twice the outpatient and inpatient HCU and
twice the annual medical costs compared to non-MUPS
patients [8]. Studies that have been performed on this
topic used different methodological approaches. Many of
them used a retrospective design [8, 14, 15], only in-
cluded patients from primary care [3, 8, 13, 16] or only
included patients with severe MUPS [3, 17]. As far as we
know, only one recent study used a prospective design
with extended follow-up and included a large sample of
participants from the general population [18].
It is also known that MUPS frequently co-occur with
depressive and/or anxiety disorders [19–21]. This is of
great clinical relevance as this ‘cosyndromality’ leads to
more disability, impairment and high HCU [8, 18, 22].
The same applies to some personality traits such as neur-
oticism. Although in literature most research has been
performed on personality disorders that are associated
with MUPS [23], Noyes et al. suggested that certain per-
sonality traits co-occurring with MUPS could lead to in-
creased care seeking behaviour [24]. These findings raise
the question what the independent association of MUPS
with HCU is and to what extent personality traits and de-
pressive and anxiety disorders add to this association.
For our study, we used data from the Netherlands Study
of Depression and Anxiety, a large naturalistic multisite
longitudinal cohort. Data on MUPS, HCU, depressive and
anxiety disorders and personality traits were all collected
over time from a large sample of participants from several
health care settings. Therefore, this cohort is ideally suited
to investigate the following research questions: What is
the association between MUPS and HCU over 2 years?
And, to what extent is the association between MUPS and
HCU influenced by depressive and/or anxiety disorders
and specific personality traits?
Methods
Design, setting and study sample
The Netherlands Study of Depression and Anxiety
(NESDA) aims to describe the long-term course and
consequences of depressive and anxiety disorders and to
examine its predictors. A detailed description of its ra-
tionale and design has been published elsewhere [25]. In
summary, the study sample consisted of 2981 partici-
pants (age 18–65) with current depressive and/or anxiety
disorders, participants with a lifetime risk or subtreshold
depressive and/or anxiety symptoms and healthy con-
trols. Recruitment took place across primary care prac-
tices (n = 1610), outpatient secondary mental health care
institutions (n = 807) and the general population (n =
564). Exclusion criteria were not being fluent in the
Dutch language and a primary diagnosis of a psychotic,
obsessive compulsive, bipolar or severe substance abuse
disorder. Baseline data were collected between 2004 and
2007. Assessments, including written questionnaires and
interviews, were repeated after 1, 2, 4 and 6 years. Non-
response among participants was not significantly re-
lated to mental health status, but slightly higher among
younger and male respondents. The research protocol
was approved centrally by the ethical review board of
VU University medical center. Subsequently it was
approved by the local ethical review boards of Leiden
University Medical Center and University Medical Center
Groningen. The study was performed in accordance with
the ethical standards of the Declaration of Helsinki. All
participants provided written informed consent.
For the present study, we used data of all participants
who completed the questionnaire used for our study,
and used the measurements at baseline (T0), one (T1)
and 2 years (T2) of follow-up. Baseline measurements
were obtained from 2981 participants. At T1 and T2,
2045 (68.6 %) and 2395 (80.3 %) participants had a
follow-up assessment, respectively.
Health care use (HCU), the outcome
HCU was measured with the Trimbos and iMTA ques-
tionnaire on costs associated with psychiatric illness
(TIC-P) [26]. The TIC-P is a widely used, feasible and
reliable questionnaire on health care consumption and
productivity losses for patients with mental health disor-
ders. For this study we focused on the first part of the
TIC-P, consisting of dichotomous questions on relevant
medical services, followed by a question on the con-
sumption volume (number of contacts) in the past
6 months; e.g. ‘did you consult with a family physician?
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No/Yes, namely … times’. We counted the number of
medical services used (range 0–14) and additionally cate-
gorized these into three subgroups: mental health care ser-
vices (primary care psychologists, social workers/social
psychiatric nurses, secondary mental health care institu-
tions, centers for drugs or alcohol, self-help groups and
private psychiatrists/psychotherapists); somatic health care
services (family physicians, medical specialists and hos-
pital admissions); and miscellaneous health care services
(homecare, complementary alternative professionals, oc-
cupational health physicians, physiotherapists). Partici-
pants completed the TIC-P at T0, T1 and T2.
Medically unexplained physical symptoms (MUPS), the
determinant
MUPS were measured with the somatisation scale of the
validated Four Dimensional Symptoms Questionnaire
(4DSQ) [27]. The self-report 4DSQ has been developed
to measure distress, depression, anxiety and somatisation
as separate dimensions. The somatisation scale com-
prises 16 items including physical symptoms that often
remain medically unexplained (e.g. dizziness and abdom-
inal pain). The scale highly correlates with instruments
used in other countries measuring MUPS; 0.82 in case
of the SCL-90 [27, 28] and 0.84 in case of the PHQ-15
[29, 30]. In the present sample Cronbach’s alpha of the
4DSQ somatisation scale was 0.92, 0.89 and 0.97 at the
three measurements, respectively. The items on the
somatisation scale are scored on a 5-point Likert scale:
“no”, “sometimes”, “regularly”, “often”, and “very often
or constantly”. In order to arrive at scale scores, the re-
sponses were recoded as 0 for “no”, 1 for “sometimes”
and 2 for “regularly”, “often” and “very often or con-
stant” and summated, resulting in a score ranging from
0 to 32. Additionally, in order to facilitate clinical use
and to overcome the fact that there is no linear relation
between MUPS and HCU, we repeated the analyses with
a dichotomized scale using 11 points as a cut-off score,
since a score of 11 or higher is considered to indicate
MUPS [27]. Participants completed the 4DSQ at T0, T1
and T2.
Depressive and anxiety disorders
The presence of depressive and anxiety disorders was
assessed with the validated Composite International
Diagnostic Interview (CIDI, WHO 2.1) at T0 and T2.
Trained research staff interviewed all participants. De-
pressive disorders included major depressive disorder
and dysthymia. Anxiety disorders included generalized
anxiety disorder, panic disorder with or without
agoraphobia, social phobia and/or agoraphobia with-
out panic disorder. We only took into account diag-
noses established during the previous six months at
both assessments.
Personality traits
Personality traits were measured with the NEO Five
Factor Inventory (NEO-FFI) at T0 and T2. The NEO-
FFI measures the five most important personality do-
mains in adults: neuroticism, extraversion, openness,
agreeableness and conscientiousness. Each domain is
measured with 12 items, using a five-point Likert re-
sponse format (sum score: range 12–60). More detailed
information about the contents, validity and reliability of
the NEO FFI has been published elsewhere [31–33].
Sociodemographic variables and chronic diseases
Based on previous studies, we considered the following
sociodemographic variables as possible confounders:
gender, age, level of education, marital status and the
number of chronic diseases [34, 35]. The level of educa-
tion was derived from the standard classification of edu-
cation from Statistics Netherlands [36] and categorized
into three groups (basic, intermediate, high). Marital sta-
tus divided participants in those being married/living
with a partner and those living alone. Participants were
asked if they had one or more diseases from the follow-
ing chronic diseases categories: respiratory, cardiometa-
bolic, musculoskeletal, digestive, neurological, endocrine
and cancer. We only considered and summated the dis-
eases if participants were currently treated with medica-
tion and/or under specialist control. All variables were
assessed at T0.
Statistical analysis
Descriptive statistics are presented as mean with stand-
ard deviation for normally distributed continuous data,
median and inter-quartile range for skewed continuous
variables and as numbers and percentages for dichotom-
ous and categorical variables.
Generalized estimating equations (GEE) with an ex-
changeable correlation structure were used to assess the
relationship between MUPS and HCU longitudinally
(Fig. 1). We used GEE because it takes into account the
dependency of repeated observations within the partici-
pants and because it is capable of analysing non-complete
longitudinal data. As the total number of consulted med-
ical services showed a Poisson distribution, we used
Poisson GEE analysis to assess its association with MUPS.
For the total number of contacts, we used negative bino-
mial GEE analysis because the Poisson distribution was
skewed to the right (a Poisson distribution with overdis-
persion). The effect sizes of both the Poisson and the
negative binomial GEE analyses are expressed as rate ra-
tios (RRs). This RR represents the association between
MUPS and HCU on average over time and reflects both a
within and between subjects interpretation [37]. Besides
crude analyses, we adjusted the relationships for the socio-
demographic variables, and additionally we examined the
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influence of depressive and anxiety disorders and person-
ality traits on the association between MUPS and HCU.
The influence is expressed as the percentage decrease in
the regression coefficient as a result of including each sep-
arate variable. As depressive and anxiety disorders and
personality traits were only measured at T0 and T2, these
last analyses were based on these two measurements only.
We repeated the crude and adjusted analyses for each of
the three medical resource subgroups. Furthermore, as we
performed our analyses in a population with an oversam-
pling of depressive and anxiety disorders, we analysed
whether the effect between MUPS and HCU was modified
by depressive and/or disorders by adding an interaction
term to the model. Finally, we carried out the same set of
analyses with a time lag model in order to assess if MUPS
at a certain point in time was related to HCU one year
later (Fig. 1). We used all observations in our analyses.
All regression coefficients were considered to be statisti-
cally significant when the p-value was below 0.05. All stat-
istical analyses were performed in SPSS 20.0 for Windows.
The reporting of this manucripted adhered to the
STROBE guidelines (Additional file 1).
Results
Table 1 shows the descriptive information of all variables
used in this study. At baseline, the mean age was 42 years
and 66 % were women. The mean score for MUPS was
10 at T0, 8.6 at T1 and 8.1 at T2. When using the clin-
ical cut-off point of 11, 42 % had MUPS at T0, 27 % at
T1 and 25 % at T2.
The longitudinal association between MUPS and HCU
MUPS were significantly associated with the total num-
ber of consulted medical professionals and the total
number of associated contacts, respectively, on average
over time in both the crude and adjusted GEE analyses
(Table 2). To illustrate the interpretation of the results:
the estimated adjusted RR of 1.02 found for MUPS in re-
lation to the total number of medical resources can be
interpreted as follows: for every unit increase in the
4DSQ, a 2 % increase in the number of medical services
is observed, within and between participants. The small
difference between the crude and adjusted analyses was
mainly driven by the number of chronic diseases. MUPS
defined with the dichotomized 4DSQ showed results in
the same direction (services: RR 1.35; 95 % CI 1.31–1.40;
contacts: RR 1.41; 95 % CI 1.28–1.55, not in table). Out-
come defined as the three categories of medical services
also showed comparable results (Table 2). The strongest
association was found for both the number of mental
health care services used and the number of contacts
with these services. Table 3 shows the influence of de-
pressive and anxiety disorders and personality traits on
the association of HCU with MUPS. For both HCU out-
comes, neuroticism had the strongest influence, followed
by depressive disorders. When taking neuroticism and
depressive disorders together, the magnitude of the re-
gression coefficient decreased by 48 % (services) and
44 % (contacts). Despite the contribution of these mental
health characteristics, HCU remained significantly asso-
ciated with MUPS. Adding anxiety disorders and other
personality traits did not further affect the association.
Also for the dichotomized 4DSQ score, neuroticism and
depressive disorders together showed the strongest influ-
ence (decrease in regression coefficients of 56 and 59 %,
respectively) and HCU remained significantly associated
with MUPS. When we examined whether the association
between MUPS and HCU was modified by depressive
and/or anxiety disorders, we found a significant inverse
interaction effect (p < 0.001), meaning that the associ-
ation between MUPS and HCU (both services and con-
tacts) was weaker for patients with depressive and
anxiety disorders (data not shown).
MUPS related to HCU one year later
Table 4 shows the results of the time-lag analyses. When
comparing the results of the time-lag analyses with the
standard analyses, we found comparable RRs for the
number of medical services, but slightly higher RRs for
the number of contacts in the time-lag analyses. For the
dichotomized 4DSQ score, results were in the same dir-
ection (services: RR 1.19; 95 % CI 1.15–1.22; contacts:
RR 1.64; 95 % CI 1.48–1.83). For the influence of depres-
sive and anxiety disorders and personality traits on the
association between MUPS and HCU, we found the
same pattern with neuroticism as the strongest influen-
cing variable, followed by depressive disorder and again
even stronger when taken together (data not shown).
MUPS was still associated with HCU over a longer
Fig. 1 Analysis models T0: baseline; T1: 1 year follow-up; T2: 2 years
follow-up. MUPS: medically unexplained physical symptoms. HCU:
health care use
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Table 1 Sample characteristics
Baseline One year follow-up Two year follow-up
Socio-demographics
Females, number (%) 1979 (66.4)
Age in years, mean (SD) 41.9 (13.1)
Level of education, number (%)
Basic 199 (6.7)
Intermediate 1736 (58.2)
High 1046 (35.1)
Number of chronic diseases, mean (SD) 0.6 (0.9)
Married or with partner, number (%) 2066 (69.3)
MUPS (4DSQ somatisation scale)
Total score (0–32), mean (SD) 10.0 (7.1) 8.6 (6.7) 8.1 (6.3)
Dichotomized: number with MUPS (≥11) (%) 1237 (42.0) 806 (27.0) 741 (24.9)
Health Care Use (TIC-P)
Total number of medical services (0–12), mean (SD) 2.4 (1.5) 2.5 (1.6) 2.9 (1.8)
Mental health care services 0.6 (0.8) 0.5 (0.8) 0.6 (0.9)
Somatic health care services 1.2 (0.7) 1.4 (0.8) 1.4 (0.9)
Miscellaneous health care services 0.6 (0.8) 0.7 (0.8) 0.8 (0.9)
Total number of contacts with medical services, median (IQR) 7.0 (14.0) 9.0 (19.0) 12.0 (28.0)
Mental health care contacts 0.0 (5.0) 0.0 (5.0) 0.0 (8.0)
Somatic health care contacts 3.0 (4.0) 4.0 (4.0) 3.0 (5.0)
Miscellaneous health care contacts 0.0 (5.0) 0.0 (6.0) 2.0 (14.0)
Depressive or anxiety disorders (CIDI), number (%)
Depressive disorders 1158 (38.8) - 626 (21.0)
Anxiety disorders 1305 (43.8) - 711 (23.9).
Personality score (NEO-FFI; 12–60), mean (SD)
Neuroticism 36.3 (9.4) - 33.5 (9.0)
Extraversion 36.9 (7.4) - 37.8 (7.2)
Openness 38.2 (6.0) - 36.8 (5.3)
Agreeableness 43.8 (5.3) - 44.5 (5.2)
Conscientiousness 41.7 (6.5) 42.3 (6.2)
MUPS medically unexplained physical symptoms, 4DSQ four dimensional symptom questionnaire, TIC-P Trimbos and iMTA questionnaire on costs associated with
psychiatric illness, IQR interquartile range (25th to 75th percentile), CIDI composite international diagnostic interview, NEO-FFI NEO five-factor inventory
Table 2 MUPS and HCU over time: GEE standard analyses
Crude RR (95 % CI) Adjusted RR (95 % CI)
MUPS and total number of medical services 1.022 (1.020–1.024) * 1.020 (1.017–1.022) *
Somatic services 1.013 (1.011–1.015) * 1.009 (1.006–1.011) *
Mental health care services 1.035 (1.030–1.039) * 1.035 (1.030–1.040) *
Miscellaneous health care services 1.027 (1.023–1.031) * 1.026 (1.021–1.030) *
MUPS and total number of contacts 1.045 (1.040–1.052) * 1.037 (1.030–1.044) *
Somatic contacts 1.044 (1.040–1.048) * 1.031 (1.027–1.035) *
Mental health care contacts 1.046 (1.035–1.058) * 1.044 (1.031–1.057) *
Miscellaneous health care contacts 1.042 (1.034–1.050) * 1.029 (1.020–1.038) *
* All RRs including 95 % CIs were significant with p-values below 0.001. The adjusted RRs were adjusted for the sociodemographic variables and chronic diseases.
All measurements include T0, T1 and T2. Mental health care services: primary care psychologists, social workers/social psychiatric nurses, secondary mental health
care institutions, centers for drugs or alcohol, self-help groups and private psychiatrists/psychotherapists. Somatic health care services: family physicians, medical
specialists and hospital admissions. Miscellaneous health care services: home care, complementary professionals, occupational health physicians and physiotherapists
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period of time, as reflected in the time lag analyses (data
not shown).
Discussion
In the present study we found a positive association be-
tween MUPS and HCU over 2 years taking into account
all measurements, both for the number of medical ser-
vices as well as the associated contacts. After adjusting
for depressive and anxiety disorders and personality
traits, the associations weakened, especially due to de-
pressive disorders and neuroticism, but remained statis-
tically significant.
Comparison with literature
Our findings on the positive association between MUPS
and HCU are in accordance with previous studies, irrespect-
ive of the differences in methodology [8, 10, 13, 17, 18, 22].
However, when we examined the three categories of med-
ical resources, we found the strongest association between
MUPS and mental HCU, in contrast to some other studies
[8, 13, 18]. Fink et al. concluded in their study among pa-
tients with somatoform disorders that these patients used
more non-psychiatric health care facilities than patients
without somatoform disorders [13]. Also Barsky et al. found
large amounts of medical, but not mental, health care use
among their somatising patients [8]. Their findings support
the assumption that patients with MUPS attribute their
complaints to their physical symptoms, thereby seeking
somatic health care instead of mental health care. The dif-
ference with our findings could be explained by the
difference in setting (primary care only versus primary care,
mental health care and general population).
We found that depressive disorders and neuroticism
had the strongest influence on the association between
MUPS and HCU over time. As far as we know, no re-
search has been published on the comorbidity of MUPS
with psychiatric disorders and personality traits with re-
gard to HCU, especially not in a longitudinal design. De
Waal et al. found that somatoform disorders and depres-
sive disorders were almost equally associated with HCU,
but that the undifferentiated somatoform disorder had
an independent effect after adjusting for psychiatric dis-
orders [22]. Noyes et al. found that MUPS were associ-
ated with specific personality traits as neuroticism and
that this led to increased care seeking behaviour, which
is in accordance with our findings [24]. However, in con-
trast with our findings, Carlier et al. found no associ-
ation between somatoform disorders and specific
personality traits in their cross-sectional study [38]. As
an explanation for this result they argued that their
somatoform disorders patients were mostly highly
educated and married, indicating a stable personal
life.
Generalizability of the results
One should realize that we examined the relation be-
tween MUPS and HCU in a sample with predominantly
depressive and/or anxiety disorders. This may impede
the interpretation and generalizability of the results.
Therefore, we investigated possible effect modification
between MUPS and depressive disorders and between
Table 3 MUPS and HCU over time, adjusted for depression, anxiety and personality: GEE standard analyses
MUPS and number of medical
services (RR; 95 % CI)
Percentage decrease in
regression coefficient
MUPS and number of
contacts (RR; 95 % CI)
Percentage decrease in
regression coefficient
Adjusted RR a 1.021 (1.019–1.024)* 1.041 (1.034–1.048)*
Depressive disorders 1.015 (1.013–1.018)* 29 1.031 (1.024–1.039)* 24
Anxiety disorders 1.018 (1.015–1.020)* 14 1.034 (1.026–1.042)* 17
Neuroticism 1.013 (1.011–1.016)* 38 1.027 (1.018–1.036)* 34
Extraversion 1.018 (1.016–1.021)* 14 1.036 (1.028–1.044)* 12
Openness 1.021 (1.019–1.024)* 0 1.041 (1.034–1.048)* 0
Agreeableness 1.021 (1.019–1.024)* 0 1.039 (1.031–1.047)* 5
Conscientiousness 1.020 (1.017–1.022)* 0 1.037 (1.030–1.045)* 10
Neuroticism & Depressive disorders 1.011 (1.008–1.014)* 48 1.023 (1.015–1.032)* 44
* All RRs were significant with p-values below 0.001. a All analyses were based on measurements at T0 and T2, as depression, anxiety and personality were not
measured at T1. Therefore, a new rate ratio was calculated, adjusted for sociodemographic variables and chronic diseases
Table 4 MUPS related to HCU 1 year later: GEE time-lag analyses
Crude RR (95 % CI) Adjusted RR (95 % CI)
MUPS and number of medical services 1.021 (1.018–1.023)* 1.018 (1.015–1.020)*
MUPS and number of contacts 1.060 (1.053–1.067)* 1.051 (1.043–1.058)*
*All RRs were significant with p-values below 0.001. The adjusted RRs were adjusted for the sociodemographic variables and chronic diseases. MUPS were
measured at T0 and T1. HCU was measured at T1 and T2
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MUPS and anxiety disorders. These analyses showed
that within the population without these disorders the
relationship between MUPS and HCU was stronger than
in the population with these disorders. Based on those
analyses, we believe that the observed relations may also
hold for the general population.
Strengths and limitations
A main strength of our study was that we used the
NESDA cohort to answer our research questions. By using
this cohort, longitudinal data over 2 years from a large
sample of participants were available, recruited from both
primary care, secondary mental health care and the gen-
eral population. Also, we adjusted all analyses for chronic
somatic diseases. Furthermore, we used structured diag-
nostic interviews and not only self-report questionnaires.
However, our findings should be interpreted in the light
of several limitations. First, the NESDA cohort study used
the 4DSQ somatisation scale to measure MUPS. As with
all existing MUPS questionnaires, it lacks judgement of a
clinician to verify that symptoms are really unexplained
[39]. However, the 4DSQ highly correlates with the PHQ-
15 and SCL-90, questionnaires that are widely used to
measure MUPS [27], and may be considered as an
adequate proxy measure for MUPS. Second, HCU was
measured over the past 6 months, while MUPS were mea-
sured over the past week, leading to incongruence. How-
ever, we do not believe that the results were affected
much by this. We found a correlation coefficient of 0.72
of MUPS over the 2 years (data not shown), indicating a
quite stable pattern of MUPS over time. Also, our time-
lag analyses showed results that were similar to those of
the standard analyses, with even a slightly higher effect of
MUPS on HCU for the number of contacts. Third, as
HCU was asked over the past 6 months, the risk of recall
bias exists. However, the direction of this bias is unclear.
Other studies have used electronic medical records to as-
sess HCU, but these can also be incomplete [40]. Fourth,
we have no information on the actual reasons for health
care use and have only assessed the quantity and not the
appropriateness of provided health care. Also we did not
control for the use of psychopharmacological therapy
which could have influenced the results, nor can we deter-
mine whether MUPS were the primary problems or symp-
toms from a psychiatric disorder. Fifth, only the baseline
sociodemographic variables and number of chronic dis-
eases were included as covariates in the analyses, although
several of these covariates may have changed over the
course of 2 years. However, we do not believe that the re-
sults of our adjusted analyses would be different because
the influence of these covariates was only marginal. Fi-
nally, based on our study we cannot infer causality. There-
fore it might at least theoretically be possible that an
increase in HCU is leading to more MUPS.
Implications for clinical practice and future research
As we found that MUPS are independently associated
with HCU, attention should be paid to early identification
and adequate treatment of MUPS in clinical practice.
Also, physicians should be aware of signs of depression
and anxiety and personality traits as they have an influ-
ence on the association between MUPS and HCU.
A possible explanation for prolonged high HCU is that
care for patients with MUPS is often fragmented, as
diagnostics and treatments are carried out by different
health care providers. To reduce high and possibly inad-
equate health care for these patients, the issue of ad-
equacy and fragmentation of health care patterns should
be further examined, also in relation to the patient’s
quality of life. Guidelines for MUPS across disciplines
and different health care settings may be instrumental in
this examination [41, 42].
Also, it would be interesting to examine the role of
health anxiety as a predictor of HCU in a longitudinal
design. As we found neuroticism to be a predictor, it is
possible that health anxiety could play an important role
as well as these are often related.
Conclusions
Our study showed that MUPS are positively associated
with HCU over time, even after adjustment for depres-
sive and anxiety disorders and personality traits. This
suggests that good MUPS management is important.
Further research is needed to investigate the adequacy of
health care use patterns and the association with the pa-
tient’s quality of life.
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